Pinion Immunotherapeutics

Founded in 2021 and headquartered in Maryland, USA, Pinion Immunotherapeutics is a clinical-stage biotechnology company advancing next-generation mRNA-LNP therapeutic vaccines and immunotherapies for infectious diseases and cancer. The company is led by an experienced scientific and operational team and supported by a world-class scientific advisory board, positioning Pinion at the forefront of the emerging wave of precision mRNA medicines